Ninth and Jefferson Building, 12th Floor
908 Jefferson Street
DPhil (University of Oxford)
MSc (University of Oxford)
MBChB (University of Cape Town (South Africa))
Dr. Barnabas is an Infectious Disease Physician-Scientist at the University of Washington and affiliate at the Fred Hutchinson Cancer Research Center. She completed her medical training at the University of Cape Town, her doctorate in mathematical modeling at the University of Oxford, and her Infectious Diseases training at the University of Washington. Her research focuses on HIV treatment and prevention, specifically on interventions that reduce HIV viral load and, consequently, disease progression and transmission. Her projects use empiric data and mathematical models to better understand HIV clinical progression and transmission, and estimate the potential impact of HIV interventions at population level. The ultimate aim of her work is to estimate the effectiveness and cost-effectiveness of HIV treatment and prevention interventions to inform public health policy.
van Rooyen H, Barnabas RV, Baeten JM, Phakathi Z, Joesph P, Krows M, Hong T, Murnane PM, Hughes J, Celum C. High HIV testing uptake and linkage to care in a novel program of home-based HIV counseling and testing with facilitated referral in KwaZulu-Natal, South Africa. J Acquir Immune Defic Syndr. 2013;64(1):e1-e8. PMCID: 3744613.
Abu-Raddad LJ, ^Barnabas RV, Janes H, Weiss H, Kublin JG, Longini IM, Wasserheit JN and the HIV Viral Load Working Group. Have the explosive HIV epidemics in sub-Saharan Africa been driven by higher community viral load?. AIDS. 2013;27(6):981-989. PMCID: 3725236.
Barnabas RV, Webb EL, Weiss HA, Wasserheit JN. The role of co-infections in HIV epidemic trajectory and positive prevention: a systematic review and meta-analysis. AIDS. 2011 May 30:1-15.
Barnabas RV, Wasserheit JN, Huang Y, Janes H, Morrow R, Fuchs J, Mark KE, Casapia M, Mehrotra DV, Buchbinder SP, Corey L; the NIAID HIV Vaccine Trials Network. Impact of Herpes Simplex Virus Type 2 on HIV-1 acquisition and progression in an HIV vaccine trial (the Step Study). J Acquir Immune Defic Syndr. 2011 Apr 5:238-244.
Barnabas RV, Laukkanen P, Koskela P, Kontula O, Lehtinen M, and Garnett GP. (2006) The Epidemiology of HPV 16 and Cervical Cancer in Finland and the Potential Impact of Vaccination: Mathematical Modelling Analyses. PLoS Med 3(5): e138.